相关实验视频

Updated: Jul 20, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

前列腺癌的骨转移:分子机制,向诊断和向治疗 (综述)

Xutang Guo¹, Shaojun Li¹

¹Department of Urology, Gansu Province Maternity and Child Health Hospital, Lanzhou, Gansu 730000, P.R. China.

Oncology reports

|February 21, 2025

概括

前列腺癌骨转移是死亡的主要原因. 本综述详细介绍了基因和非编码RNA在骨转移中的作用,有助于新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

前列腺癌 (PCa) 是全球男性癌症死亡的主要原因.
晚期PCa通常导致骨转移 (~90%的患者),导致严重的骨事件.
目前对PCa骨转移的治疗方法是息的,这突显了需要新的治疗策略的需要.

研究的目的:

综合审查蛋白质编码基因在PCa骨转移中的作用.
阐明非编码RNA在PCa骨转移的发展中的重要性.
为临床医生和研究人员提供深入的理解,以改善PCa管理.

主要方法:

关于PCa骨转移的研究的文献综述.
分析涉及蛋白质编码基因的分子机制.
研究PCa进展和骨转移中的非编码RNA功能.

主要成果:

确定了关键的蛋白质编码基因,涉及PCa骨转移途径.
突出了各种非编码RNA在调节PCa细胞行为和骨微环境中的新兴作用.
总结了新型向疗法的疗效和潜力 (例如PSMA,PARP,PD-1抑制剂).

结论:

了解PCa骨转移的分子基础对于有效的疾病管理至关重要.
蛋白质编码基因和非编码RNA是PCa骨转移的关键参与者.
本综述提供了对高级PCa的潜在治疗点的见解.

关键词:

骨转移发生在骨髓中.分子机制的分子机制.没有编码的RNAs.前列腺癌是前列腺癌.编码蛋白质的基因编码蛋白质的基因有针对性的诊断.有针对性的治疗.

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...